The anticholinergic properties of chlorphenamine are intensified by monoamine oxidase inhibitors (MAOIs). The tablets are therefore contraindicated in patients who have been treated with MAOIs within the last fourteen days.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
